跳至主要内容
临床试验/JPRN-UMIN000001412
JPRN-UMIN000001412已完成未知

To investigate the efficacy and safety of Yokukansan for patients with insomnia - To investigate the efficacy and safety of Yokukansan for patients with insomnia

The Jikei university school of medicine0 个研究点目标入组 10 人开始时间: 2008年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with insomnia that accompany schizophrenia and manic-depressive psychosis. 2) Patients with pharmacologically-induced insomnia, including anti-Parkinson`s, anti-hypertensive and steroid-type drugs. 3) Patients with insomnia due to serious psychosomatic disorders. 4) Patients who have sleep-related respiratory disorders, Periodic Limb Movement Disorder and Restless Leg Syndrome. 5) Patients who have taken Kampo medicine within the last 4 weeks. 6) Patients who have taken psychotropic drugs, anti-histamine drugs, or melatonin, etc. within the last 4 weeks. 7) Patients who have participated in research with other interventions. 8) Patients who are otherwise classified as unfit by the attending physicians for the research.

研究者

相似试验